NCT02183259View on ClinicalTrials.gov

Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

December 31, 1998

Conditions
Healthy
Interventions
DRUG

ESR 1150 CL, Capsule, oral

DRUG

ESR 1150 CL, solution, intravenous

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY